BCL2L1 and glioblastoma: As shown in Fig. 3c and Supplementary Fig. 5A and B, U87MG and murine glioblastoma cells bearing the IDH1 mutation showed decreased expression of Mcl-1, Bcl-xL, and Bcl-2.